CD8A and neoplasm: Both fasudil and AT13148 reduced HCC tumour numbers, areas, and volumes (Figure 5C–E and Figure 6C–E) indicating beneficial therapeutic actions, but neither led to increased numbers of neutrophils or CD8+ T cells in tumours relative to vehicle controls (Figure 5F–G and Figure 6F–G).